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Abstract.  We have generated a  set of amino- and 
carboxy-terminal deletions of the neurofilament NF-M 
gene and determined the molecular consequences of 
forced expression of these mutant constructs in mouse 
fibroblasts. To follow the expression of mutant NF-M 
subunits in transfected cells, a  12 amino acid epitope 
(from the human c-myc protein) was expressed at the 
carboxy terminus of each mutant.  We show that NF-M 
molecules missing up to 90 or 70% of the nonhelical 
carboxy-terminal tail or amino-terminal  head domains, 
respectively, incorporate readily into an intermediate 
filament  network comprised either of vimentin or NF-L, 
whereas deletions into either the amino- or carboxy- 
terminal  a-helical  rod region generate assembly- 
incompetent polypeptides. Carboxy-terminal deletions 
into the rod domain invariably yield dominant mutants 
which rapidly disrupt the array of filaments comprised 
of NF-L or vimentin.  Accumulation of these mutant 
NF-M subunits disrupts vimentin filament arrays even 
when present at ,,o1% the level of the wild-type 
subunits.  In contrast,  the amino-terminal  deletions into 
the rod produce pseudo-recessive mutants that perturb 
the wild-type NF-L or vimentin arrays only modestly. 
The inability of such amino-terminal  mutants to dis- 
rupt wild-type subunits defines a  region near the 
amino-terminal  a-helical  rod domain (residues 75-126) 
that is required for the earliest steps in filament as- 
sembly. 
T  rtE euka~otic cytoskeleton is comprised of microtu- 
bules,  actin  filaments  and  intermediate  filaments 
(IFs) ~  that together with associated proteins localized 
at nuclear and plasma membrane binding  sites establish the 
internal cytoarchitecture of most eukaryotic cells. While the 
dynamics and functional  role of microtubules and actin fila- 
ments are well characterized, neither the assembly charac- 
teristics  nor the function of IFs are firmly established (for 
reviews,  see Klymkowsky et al.,  1989; Steinert  and Liem, 
1990).  Based  on  DNA  sequence  data  and  their  tissue- 
specific expression, IFs can be subdivided into six distinct 
groups: vimentin  (mesenchymal  Cells), keratins  (epithelial 
cells,  desmin (muscle  cells), glial  fibriUary acidic  protein 
(glial cells), lamins (all cell types), and neurofilaments (NFs) 
(neuronal  cells).  There  is  no reason to believe that  these 
comprise the entire  family of IF subunits,  a point under- 
scored by the recent identification of three additional IF pro- 
teins expressed in different subsets of neurons. These include 
peripherin,  a  vimentin-like  IF polypeptide expressed in a 
subset of peripheral neurons (Portier et al.,  1984; Parysek 
and Goldman, 1987; Leonard et al., 1988), a-internexin,  an 
NF-like polypeptide (Fliegner et al.,  1990), and nestin,  an 
IF protein expressed in neuroepithelial  stem cells (Lendahl 
et al.,  1990). 
All cytoplasmic IFs are characterized  by a  highly  con- 
1. Abbreviations  used in this paper: IF, intermediate filament; MSV, murine 
sarcoma virus; NF, neurofilament. 
served central  a-helical  coiled-coil  domain (•310  amino 
acids) flanked by two nonhelical  domains of variable length 
and sequence (Geisler and Weber, 1986; Franke,  1987). The 
amino- and carboxy-terminal  regions play role both in end- 
to-end and in lateral interactions  of filament assembly (Geis- 
ler and Weber,  1982; Steinert et al.,  1983; Traub and Vor- 
gias,  1983; Kaufmann et al., 1985). However, not only does 
one naturally  occurring bovine keratin  (K8) contain only a 
13 amino acid tail (Bader et al.,  1986),  Albers and Fuchs 
(1987) and van den Heuvel et al. (1987) used DNA transfec- 
tion  to  demonstrate  that  essentially  all  of the  carboxy- 
terminal  domain may be deleted for a type I keratin and for 
desmin,  respectively,  without disrupting  coassembly with 
wild-type subunits  into filaments in vivo. Recently, Albers 
and Fuchs (1989) have shown for one type I keratin that both 
the amino-terminal  and carboxy-terminal  domains  are dis- 
pensable for coassembly with normal type I and type II kera- 
tin subunits. 
Unlike most IFs, the major mammalian  NFs are coassem- 
bled from three subunits:  NF-L, NF-M, and NF-H, whose 
apparent  molecular masses on SDS-PAGE gels are 68, 150, 
and 200 kD, respectively. The NF polypeptides differ in size 
mainly as the result  of increasingly  long carboxy-terminal 
extensions (Geisler et al., 1983). In NF-M and NF-H, these 
carboxy-terminal  regions  can be highly  phosphorylated, a 
feature that in part accounts for their anomalous migration 
on  SDS-PAGE gels  (Julien  and  Mushynski,  1982,  1983; 
Carden et al.,  1985).  It seems likely that phosphorylation 
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Figure 1.  Positions of amino- 
and carboxy-terminal trunca- 
tion  mutants  in  the primary 
sequence of the mouse NF-M 
polypeptide. The  one  letter 
code has been used to display 
the primary sequence of the 
mouse NF-M polypeptide, as 
deduced from DNA sequenc- 
ing (Levy et al., 1987).  Resi- 
dues within the predicted heli- 
cal rod domain (Geisler et al., 
1985)  are  underlined.  Posi- 
tions  where  amino-terminal 
or  carboxy-terminal  trunca- 
tion mutants of NF-M begin 
or end are marked. 
(especially of NF-H, which may be phosphorylated up to 50 
times [Geisler and Weber,  1987;  Lees et al.,  1988]),  may 
play a role in the interaction of NFs with other neuronal com- 
ponents (e.g., microtubules) Oulien and Mushynski,  1983; 
Sternbevger and Sternberger, 1983; Minami and Sakai, 1985). 
The organization of the three NF proteins in the native NF 
polymer has yet to be determined. In vitro reconstitution ex- 
periments using each of the three NF subunits first demon- 
strated that (a) NF-L can self-assemble into filaments in vitro 
(Geisler and Weber, 1981; Liem and Hutchinson,  1982), (b) 
that  under  some conditions NF-M  can  also  self-assemble 
(Gardner et al.,  1984;  Tokutake et al.,  1984),  and (c) that 
NF-H  is  assembly  incompetent,  forming  abortive  short, 
curly filaments that may block filament elongation (Geisler 
and Weber,  1981),  Antibody decoration of nervous tissue 
supports this view that NF-L is a component of the NF back- 
bone,  that NF-H is involved in cross-bridge formation be- 
tween NFs (Hirokawa et al., 1984),  and that NF-M is more 
closely aligned with the NF core than is NF-H (Sharp et al., 
1982; Hirokawa et al.,  1984).  While NF-M and NF-H may 
well be involved in cross-bridge formation, determination of 
the sequences for NF-M (Geisler et al., 1984; Myers et al., 
1987; Levy et al., 1987; Napolitano et al., 1987) and NF-H 
(Lees et al., 1988; Julien et al., 1987) revealed that each car- 
ries  the  conserved --310  amino  acid rod domain.  It thus 
seems likely that each is an integral filament subunit. 
In this and the companion paper (Gill et al.,  1990),  we 
have extended our earlier study of the assembly properties 
of NF proteins (Monteiro and Cleveland, 1989) by the con- 
struction and analysis of a  series of deletions that truncate 
the carboxy- or amino-terminal domains of NF-L (Gill et al., 
1990)  and  NF-M  (this  paper).  These  latter  experiments 
define the portion of the NF-M polypeptide that is necessary 
for assembly into a normal IF network and identify a series 
of dominant mutants that disrupt IF arrays assembled from 
wild-type vimentin or NF-L even when the mutant is present 
in very low relative amounts. 
Materials and Methods 
Construction of Carboxy-Terminal Deletions of NF-M 
The construction of the parental plasmid pMSV-NF-M  that was used for 
generating the set of carboxy-terminal deletions was reported earlier (see 
Fig. 2 and Monteira and Cleveland, 1989). This plasmid contains the com- 
plete mouse NF-M gene linked to the murine sarcoma virus (MSV) long 
terminal repeat. To generate a set of carboxy-terminal  deletions of NF-M, 
pMSV-NF-M  was digested at the Nco I site located 3' to the site of polyade- 
nylation, followed  by treatment with exonuclease  HI. After creating blunt- 
ended molecules with mung bean nuclease, the fragments were cleaved at 
the ~nique Barn HI site at the 3' end of the NF-M gene and the resulting 
Barn HI-blunt-ended fragments were gel purified. A myc-tag  cassette con- 
taining a 12 amino acid epitope from the human c-myc  protein (see Munro 
and Pelham, 4987) was synthesized and ligated just 5' to the complete 3' 
untranslated and 3' flanking sequences of the NF-L gene to create pMYC-0 
(Fig. 2 B). pMYC-0 was linearized first with Sai I, blunted (with Klenow 
fragment), and cleaved with Barn HI. This fragment was gel purified and 
ligated to the set of pMSV-NF-M deletions, producing the desired con- 
structs, pNFM-CAx, where x denotes the number of amino acids removed 
from the carboxy terminus of NF-M (see Fig. 2 C). 
Construction of  Amino-Terminal Deletions of  NF-M 
The plasmid, pNFM-CA50 (see Fig. 2 C) was chosen as the starting con- 
struct for the generation of amino-terminal deletions of NF-M. This gene 
encodes a nearly wild-type NF-M subunit except that the last 50 carboxy- 
terminal amino acids have been replaced with the 12 amino acid epitope 
of the human c-myc  protein, pNFM-CA50 DNA was linearized at the site 
Cla I positioned near the 5' end of MSV-LTR, and a set of amino-terminal 
deletions was generated using exonuclease  III  and mung bean nuclease. The 
blunt-ended fragments were then excised  by digestion at the unique Barn HI 
site and the resulting Barn HI blunt-ended molecules were gel purified. 
To ensure that each construct retained an appropriate 5' untranslated re- 
gion and an ATG translation initiation codon, a cassette (pNFS-ATG)  was 
constructed to contain 23 bp of  the 5' untranslated region of the mouse NF-L 
gene including the coding sequences for the first two amino acids (Fig. 7 
B).  pNF5-ATG was  linearized with  Sal  I,  blunted (with  mung bean 
nuclease), and cut at the unique Barn HI site. This fragment was gel 
purified, subsequently ligated to the set of pNFM-CA50 derivatives, and 
transformed into F~cherichia  coil  strain DH1 to yield the final pNFM-NAy 
constructs shown in Fig. 7 C, where y represents the number of amino acids 
deleted from the amino terminus of NF-M. 
Plasmid DNA from the pNFM-Ctx and pNFM-NAy series were par- 
tiaily sequenced by the dideoxy-chain  termination method to determine the 
deletion end points and to identify those that were linked in the correct 
translational reading frame to the myc tag. 
Construction of NF-M Mutants Deleted in Both Head 
and Tail Domains 
To construct an NF-M gene lacking both head and tail domains, pNFM- 
CA391 DNA was excised with Cla I and Sac II and the 6.2-kb vector- 
containing fragment (missing 391 residues of the carboxy-tail domain) was 
gel purified. The small Cla I/Sac II fragments of either pNFM-NA42 and 
pNFM-NA75 (containing portions of  the amino-head  domain) were also gel 
purified. The Cla I/Sac lI fragment from pNFM-CA391 was then ligated 
The Journal of Cell Biology, Volume 111,  1990  1988 to the Cla I/Sac II fragments of either pNFM-NA42 or pNFM-NA75 to 
generate pNFM-NA42/CA391 or pNFM-NA75/CA391,  respectively. 
Construction of  Expression Plasmids 
Containing Sequences Encoding the myc tag 
Fused to the Bacterial Gene trpE 
To construct a chimeric gene that expresses the 12 amino acid myc epitope 
as a fusion with the bacterial protein trpE protein, the insert from pMYC-O 
(Fig.  2 B) was ligated in the correct orientation into the unique Hind IH 
site of the trpE gene in pATH2 (kindly provided by Dr. T. J. Koerner, Duke 
University,  Durham, NC) and transformed into E.  coli strain DH1. The 
resultant fusion protein contained an amino-terminal 32 kD of the bacterial 
protein trpE linked to the 12 amino acid myc epitope.  The fusion protein 
was induced with indoleacrylic acid and analyzed as previously described 
(Lopata and Cleveland, 1987). Inspection of Coomassie blue-stained gels 
of extracts of induced bacteria revealed induction of a distinct 33 kD trpE- 
myc fusion polypeptide.  By comparing the intensity of staining of this band 
in  known  volumes  of extract  with a  twofold  dilution series  of known 
amounts of purified bovine albumin (from a solution whose concentration 
was determined by absorbance: A2s0 [1 mg/ml] =  0.67), the concentration 
of trpE-myc fusion protein (in/zg/ml) in the extract was calculated. 
Tissue Culture and DNA Transfection 
Mouse fibroblast L cells and an L cell line stably expressing a transfected 
NF-L gene (MSV-NF9;  Monteiro and Cleveland, 1989) were maintained 
in DME medium supplemented with 10% fetal bovine serum. Cells were 
transiently transfected using the DEAE-dextran method followed 4 h later 
by a dimethyl sulfoxide treatment (Lopata et al., 1984). Cells were usually 
analyzed 40 h posttransfection. 
Stable cell lines were obtained by co-transfecting  mouse L cells with a 
10:1 mixture of the plasmid of interest and pSV2-neo (10 ~tg of DNA per 
100-mm  dish of cells) using lipofectin  (Bethesda Research Laboratories, 
Gaithersburg, MD) according to a protocol described by the supplier. Colo- 
nies that were resistant to 400 #g/ml G418 (Gibco Laboratories, Grand Is- 
land, NY) were selected and positive stable cell lines were maintained in 
DME medium supplemented with 10% fetal calf serum and G418. 
SDS Gel Electrophoresis and Immunoblotting 
Cells were usually harvested 40 h after transient transfection, lysed in 0.5 % 
(wt/vol) SDS, 50 mM Tris-Cl, pH 6.8, and the lysates  were boiled in the 
presence of 2 %/~-mercaptoethanol. Protein concentrations were measured 
with the bicinchoninic acid method (Smith et al., 1985) and equal amounts 
of extracts of total cell proteins were separated by electrophoresis on 8.5 % 
polyacrylamide gels (Laemmli, 1970), transferred onto nitrocellulose filters 
(type BA83; Schleicher & Schuell, Inc., Keene,  NH), and immunoblotted 
as described (Lopata and Cleveland, 1987). To detect mutant NF-M poly- 
peptides tagged with the myc epitope,  the filters  were  incubated with a 
mouse monoclonal anti-myc antibody Mycl-9E10 (used at 1:100 of a partial- 
ly purified culture supematant; Evan et al., 1985), followed by 125I-labeled 
sheep anti-mouse antibody (Amersham Corp., Arlington Heights, IL). For 
vimentin, a goat polyelonal  anti-vimentin antibody (ICN ImmunoBiologi- 
cals, Costa Mesa, CA) was used (at 1:400) followed by a rabbit anti-goat 
IgG (Cappell Laboratories, Malvern, PA) and 125I-labeled  protein A. 
To do quantitative immunoblotting  of  the amount of myc-tagged polypep- 
tide accumulated in any sample,  a series of twofold dilutions of a bacterial 
extract containing a  known amount of trpE-myc fusion protein was  im- 
munoblotted in parallel with the samples of interest. By densitometric scan- 
ning of the signals on the resultant autoradiograph, a standard curve was 
constructed and the amount of myc tagged protein (in micrograms) present 
in each experimental sample was determined, after correcting for the differ- 
ences in molecular weight between the trpE-myc fusion and the NF-M/myc 
tagged polypeptides.  (Since each trpE-myc  molecule and each NF-M tagged 
molecule carry one copy of the myc tag, to convert from microgram of trpE- 
myc to the equivalent microgram of NF-M tagged subunits, we multiplied 
by  (molecular weight of the NtZM/myc tagged polypeptide)/(molecular 
weight of the trpE-myc polypeptide)). 
Immunofluorescence Staining 
Cells grown on glass coverslips were immersed for 30 s at room temperature 
in stabilization buffer (4 M glycerol,  100 mM Pipes,  pH 6.9 and 1 mM 
EGTA), extracted for 30 s in stabilization buffer containing 0.5%  (wt/voi) 
Triton X-100 at room temperature (Monteiro and Cleveland, 1989). After 
repeating the first wash, the samples were fixed in -20°C methanol for 5 
min. The samples were rehydrated in PBS and incubated with an antibody 
solution (diluted  in PBS containing 1% nonfat dry milk) for 1 h at room 
temperature.  The coverslips were washed in PBS, incubated for 1 h in sec- 
ondary antibody, washed again in PBS, and mounted on glass slides using 
Aqua-mount (Lerner Laboratories, New Haven, CT). Cells were examined 
on an Olympus BH-2 microscope using epifluorescence  optics and pho- 
tographed on Kodak TMAX film.  Primary antibodies used were a mouse 
monoclonal antibody (Mycl-9E10;  Evan et al.,  1985) against the myc tag 
(used as a partially concentrated culture supernatant), a goat polyclonal an- 
tibody to vimentin (used at 1:40), and a rabbit polyclonal antibody to NF-L 
(used at 1:500; the kind gift of Dr. G. Shaw [University of Florida, Gaines- 
ville, FL]). Affinity-purified  fluorescein-  and rhodamine-conjngated anti- 
bodies specific for each of the primary antibodies were each used at 1:40 
(obtained from ICN ImmunoBiologlcals). 
Results 
Expression of Carboxy-Terminal Deletion Constructs 
in Mouse ~'broblasts 
Like other IF polypeptides, NF-M is comprised of three do- 
mains: a 103 amino acid head domain, a 308 amino acid heli- 
cal  domain  (using  the  borders proposed  by  Geisler et al. 
[1985]), and a 438 amino acid carboxy-terminal tail (the se- 
quence of the domains is shown in Fig. 1). To investigate  the 
assembly properties of the NF-M polypeptide,  we initially 
generated a set of carboxy-terminal deletion mutants starting 
from a mouse NF-M  gene in which the presumptive tran- 
scriptional promoter was replaced with the strong promoter 
of MSV (Fig. 2 A). We have previously shown that this pro- 
moter is highly active in mouse L cells (Monteiro and Cleve- 
land,  1989).  To facilitate the detection of the product en- 
coded  by  each  mutant  gene,  we  fused  a  12  amino  acid 
Figure 2. Gene constructs for expression of carboxy-terminal trun- 
cations of NF-M.  (A) Schematic drawing of the MSV-NF-M gene. 
(B) Schematic of pMYC-0,  which carries the sequences encoding 
the 12 amino acid c-myc tag (Evan et al.,  1985) followed by a TGA 
stop codon and the 3' untranslated and 3' flanking regions of the 
mouse  NF-L  gene.  (C)  Schematic  of the pNFM-CAx  series  of 
genes deleted to varying extents into the carboxy-terminal coding 
sequence of NF-M. 
Wong and Cleveland Assembly-disrupting Mutations of  NF-M  1989 Figure  3.  Immunoblot detection 
of carboxy-terminal mutant poly- 
peptides  accumulated  following 
transient transfecfion of pNFM- 
CAx constructs into either mouse 
L  cells  or  MSV-NF9  cells.  (A) 
Schematic drawing of the NF-M 
polypeptide. The helical domain 
is represented by the closed rec- 
tangles  and  the  deletion  end- 
points of specific mutants are in- 
dicated.  (B) Immunoblot detection 
of NF-M  polypeptides  accumu- 
lated 40 h after transfection. Total 
extracts  of cellular proteins  (50 
t~g per extract) from cells trans- 
fected  with  each  mutant  were 
analyzed  by  immunoblotting. 
NF-M  wild-type  and  mutant 
polypeptides were detected using 
an anti-NF-M antibody or using 
an anti-myc-tag antibody, respec- 
tively.  Lane  a,  protein  extract 
from  L  cells  transfeeted  with 
pMSV-NF-M  DNA;  lanes  b-i, 
protein extracts from L cells trans- 
fected  with  the  corresponding 
pNFM-C~x DNAs as indicated; 
lane j, protein extract from L cell 
transfeeted  with  pUC19  DNA; 
lanes k-q,  protein extracts from 
MSV-NF9 cells transfected with 
the respective pNFM-C~x DNAs. 
Molecular mass markers (in kilo- 
daltons) are indicated at the left. 
segment (from the human c-myc protein) to the carboxy ter- 
minus of each mutant (see Fig.  2,  B  and  C).  This segment 
of c-myc was chosen as a tag because a monoclonal antibody 
(Evan et al.,  1985) that recognizes this epitope on the human 
c-myc (but  not  mouse  c-myc)  was  available.  The  deletion 
end-point of each mutant was determined by DNA sequenc- 
ing  and  constructs  in  which  the NF-M  and  tag  sequences 
were linked in a continuous reading frame were selected for 
analysis  (Fig.  3. A),  Each  mutant  construct  is  denoted  by 
pNFM-CAx, wherex refers to the number of amino acids re- 
moved from the carboxy terminus of NF-M (the precise posi- 
tions of the deletion end points are marked on the NF-M se- 
quence presented  in Fig.  1). 
The  deletion  constructs  were  transfected  into  mouse  L 
cells that normally express vimentin, and total cellular pro- 
teins were extracted 40 h  posttransfection.  Protein  samples 
were resolved by SDS-PAGE and analyzed by immunoblot- 
ting using the specific monoclonal antibody that binds to the 
12 amino acid myc tag.  As shown in Fig.  3 B  (lanes b-i), 
a myc-tagged protein band was detected in extracts from ceils 
transfected with each mutant and the  sizes were consistent 
with  that  predicted  on  the  basis  of sequence  analysis.  By 
Figure 4.  NF-M molecules missing up to 90% of the nonhelical carboxy-tail domain incorporate readily into the vimentin network of L 
cells, whereas deletions near to the carboxy-terminal helical domain disrupt assembly of the vimentin array. Mouse L cells grown on cover- 
slips were transfected with plasmids pNFM-CA50 (A and B), pNFM-CA391  (C and D), pNFM-CA429 (E and F), or pNFM-CA443 
(G and H). (.4, C, E, and G) The mutant NF-M polypeptides were visualized 40 h after transfection using Mycl-9EI0 monoclonal antibody 
(that recognizes the carboxy-terminal myc tag) followed by fluorescein-conjugated rabbit anti-mouse IgG; (B, D, F,, and H) vimentin was 
visualized in the same transfected cells using double immunofluorescence with a goat polyelonal vimentin antibody followed by a rhod- 
amine-conjugated rabbit anti-goat IgG. Bar,  10 t~m. 
The Journal of Ceil Biology, Volume 111, 1990  1990 Figure  5. Accumulation of mutant NF-M polypeptides in cell lines stably transfected with pNFM-CAx. Total cell extracts from cells stably 
transfected with genes encoding tagged NF-M subunits truncated at their carboxy termini were immunoblotted (20 t~g/lane) using the myc- 
tag monoclonal antibody to quantify the accumulation levels. A series of  twofold dilutions of  a bacterial extract containing a known amount 
of a trpE/myc fusion protein (shown in nanograms) were immunoblotted in parallel (lanes a-f). Similar extracts from mouse L cells stably 
transfected with pNFM-CASO  (lanes  g-i), pNFM-CA197 Oanes  j-m), pNFM-CA391 (lanes n-p), pNFM-CA429 0ane q), pNFM-CA433 
(lanes r-t), pNFM-CA438 (lanes u and v), and pNFM-CA443  (lane w) were also immunoblotted. The same blot was probed for vimentin 
using a goat polyclonal vimentin antibody as shown in the bottom panel. For the top panel molecular mass markers in kilodaltons  are 
indicated at the left. 
generating a set of standards using parallel immunoblotting 
with known amounts of a bacterial fusion protein carrying 
a carboxy-terminai myc tag and a similar set of standards for 
vimentin,  we determined that the average ratio of mutant 
NF-M polypeptide to endogenous vimentin in the 20%  of 
ceils successfully transfected ranged from =1:3 (for pNFM- 
CA197) to =1:20 (for pNFM-CA433). 
NF-M Mutants Missing Up to 90% of the 
Nonhelical Carboxy-tail Domain Incorporate Readily 
into the Vimentin Network of  L Cells 
To determine whether the deletion of a portion of the 438 
amino acid nonhelical carboxy-terminal tail domain of NF-M 
would interfere with its ability to assemble into a vimentin 
filament network, L  cells were transiently transfected with 
the  gene  constructs  shown  in  Fig.  3  (i.e.,  pNFM-CA50 
[deleted 50 amino acids] through pNFM-CA443 [deleted 443 
amino acids]). Transfected ceils were examined by indirect 
immunofluorescence using the monoclonal antibody against 
the myc tag to visualize the presence of NF-M derivatives 
and a polyclonal antibody against vimentin to detect the en- 
dogenous vimentin network. As shown in Fig. 4, A and B, 
the product of pNFM-CA50 was invariably coloealized with 
the endogenous vimentin network of L  cells. Thus, neither 
Figure 6. Low levels of the NF-M polypeptides deleted into the carboxy-terminal helical domain disrupt the vimentin network when ex- 
pressed  constitutively. Stably transfected cell lines (A and B) NFM-CA50F,  (C and D)NFM-A433D,  (E and F) NFM-CA438D,  and 
(G and H) pNFM-CA443E  were examined by double-label immunofluorescence. (A, C, E, and G) Ceils were stained with the Myel-9El0 
monoelonal antibody (which identifies the tagged NF-M subunits) followed by fluorescein-conjugated rabbit anti-mouse IgG and (B, D, 
F,, and H) a goat polycloual  vimentin antibody to detect the endogenous vimentin  network,  followed by rhodamine-eonjugated  rabbit 
anti-goat IgG. Bar,  10 tzm. 
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NAy. (A) Schematic diagram of plasmid, pNFM-CA50 that was 
used for generating the set of amino-terminal deletions constructs. 
(B) Schematic  diagram of  pNF5-ATG which contains the MSV pro- 
moter segment fused to the 5' untranslated region of the mouse 
NF-L gene, followed  by the NF-L translation initiation codon and 
codon 2 (serine, AGT). (C) Schematic  drawing of pNFM-NAy, the 
set of amino-terminal deletion constructs. 
the presence of the tag nor the loss of carboxy-terminal se- 
quences altered the competence of NF-M polypeptides to in- 
corporate into vimentin arrays. Even NF-M molecules miss- 
ing  as  many  as  391  residues  ('~90%  of the  nonhelical 
carboxy-tail domain) also assembled into the vimentin array 
without any detectable affect upon cytoskeletal morphology 
(Fig. 4, C and D). Thus, the carboxy-tail domain of NF-M 
is largely dispensable for proper coassembly into an array of 
filaments that, at least by light microscopy, appears normal. 
Mutations Near to or Vdthin the Carboxy-terminal Rod 
Domain Are IF  Array-disrupting Dominant Mutants 
In contrast to the normal pattern of assembly observed after 
expression of mutants retaining >10 % of the 438 amino acid 
nonhelical carboxy-terminal tail domain, a mutant retaining 
only 9 amino acids of the tall (pNFM-CA429) yielded two 
distinct phenotypes. In 80%  of the cells, the tagged NF-M 
subunits were coaligned with what was an apparently normal 
vimentin array (e.g., the cell at the left in Fig. 4 E); however, 
in the remaining 20%, mutant NF-M both failed to assemble 
with vimentin and caused a dramatic reorganization of the 
vimentin network, a phenotype never seen with mutants car- 
rying substantially larger portions of the tail. For example, 
as illustrated in the cell to the right in Fig. 4, E and F, the 
mutant NF-M was colocalized with vimentin into a series of 
punctate,  cytoplasmic aggregates and a  collapsed perinu- 
clear mass of disrupted vimentin filaments. Since the cells 
in which IF assembly was disrupted were among the most 
intensely stained with the myc antibody, we interpret this to 
mean that when expressed at sufficient levels truncated NF-M 
polypeptides are IF array-disrupting dominant subunits. 
The situation for mutants deleted four or five amino acids 
into  the  a-helical  rod  domain  (e.g.,  constructs  pNFM- 
CA442 [not shown] or pNFM-CA443 [Fig. 4, G and HI) was 
even more striking: in >70%  of the transfected cells trun- 
cated NF-M caused a complete disruption of vimentin ilia- 
merits,  while the remainder showed partial disruption. No 
myc positive cells displayed a wild-type vimentin array. 
We conclude that most, but not all, of the 438 amino acid 
carboxy-terminal tail is dispensable for assembly of NF-M 
into IF arrays constructed primarily of wild-type vimentin 
subtmits.  Further deletion to include amino acids within the 
rod domain yields array-disrupting mutants. 
Even Low Levels of  NF-M Polypeptides Missing 
Four or Five Residues of the s-Helical Rod Domain 
Disrupt Vimentin Filament Arrays 
To quantify accurately the ratio of mutant NF-M required to 
disrupt  endogenous  vimentin  arrays  and  to  document 
whether assembly disruption would be deleterious to cell 
viability, cell lines were  generated that constitutively ex- 
pressed truncated NF-M subunits.  After cotransfection with 
the neomycin gene, colonies of G418-resistent L cells were 
selected and individual lines cloned. Fig. 5 shows an immu- 
noblot of twofold serial dilutions of a bacterial extract con- 
talning a known amount of a trpE-myc fusion protein (lanes 
a-f) and extracts from various stable cell lines (lanes g-w) 
using the monoclonal antibody that recognizes the myc tag. 
A wide range of levels of NF-M mutant expression was ob- 
served: when quantified with the myc fusion protein stan- 
dards, it was estimated that NF-M levels vary from 1.2 to 
0.02 % of total cellular protein in the various lines. A similar 
method has previously been used to show that vimentin con- 
stitutes ~2 % of total cellular protein in the parental cell line 
(Monteiro and Cleveland,  1989),  a  level not significantly 
changed in any NF-M expressing line (see bottom portions 
of Fig. 5). 
Each cell line stably expressing a mutant NF-M was exam- 
ined by double indirect immunofluorescence  for both mutant 
NF-M polypeptides and endogenous vimentin. Deletion of 
a portion (pNFM-CA50 to pNFM-CA433) or the entirety of 
the carboxy-terminal tail (pNFM-CA438)  yielded mutant 
NF-M polypeptides that integrated normally into the vimen- 
tin filament network (as shown in Fig. 6 for pNFM-CA50F 
[A and B], pNFM-CA433D [C and D] and pNFM-CA438E 
[E and/9. This was invariably the case even in those lines 
with the highest levels of mutant NF-M accumulation (lines 
CA197B,  CA433E,  CA438D).  These  results  differ from 
those using the transient transfection in that in all lines ex- 
pressing mutants retaining an intact rod but deleted in )90% 
of the tail (e.g., CA429 through CA438) coassembled with 
vimentin without obvious disruption. However,  this is al- 
most certainly the result of the  relative levels of NF-M/ 
vimentin.  Quantitative  immunoblotting revealed  that  the 
highest expressed mutant NF-M in these lines accumulated 
to the same 5 % of vimentin (line 433E) that was seen as the 
average  stoichiometry obtained during transient transfec- 
tion.  Presumably, the 20%  of transiently expressing cells 
that yielded disruption of IF arrays contained levels of mu- 
tant NF-M above this threshold. 
In contrast, mutations in which the entire carboxy-tail do- 
main and four or five residues of the o~-helical rod domain 
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tion of  amino-terminal mutant 
polypeptides  after  transfec- 
tion of NFM-NAy constructs 
into either mouse L cells or 
MSV-NF9 cells. (A) Schematic 
diagram  of the  NF-M poly- 
peptide. The helical domains 
are represented by the filled 
rectangles. The deletion end- 
point of each mutant is indi- 
cated  at  the  top.  (B)  Cells 
with plasmid DNAs 
were lysed 40 h after transfec- 
tion and total cellular proteins 
were resolved by SDS-PAGE. 
NF-M  mutant  polypeptides 
were detected by immunoblot- 
ting  using  the  Myel-9E10 
monoelonal  antibody. (Lane 
a) Protein extract from L cells 
transfected with pNFM-NA50 
DNA,  and  (lanes  b-g)  the 
respective pNFM-CAy DNAs. 
(Lanes h-m) Protein extracts 
from  M,SV-NF9 cells  trans- 
fect~.~th  the  respective 
pNF-M-NAy DNAs. Molecu- 
lar mass markers  in kilodal- 
tons are indicated at the left. 
were deleted yielded lines in which the assembly of the en- 
dogenous vimentin network was partially disrupted (illus- 
trated for NFM-CA443E in Fig. 5, G and H). For these mu- 
tants,  most  NF-M  was  colocalized  with  vimentin  into 
punctate aggregates scattered throughout the cytoplasm, al- 
though some filamentous staining juxtaposed to the nucleus 
was also apparent both for vimentin and for the mutant NF-M. 
This disruption (albeit incomplete) of the normal vimentin ar- 
ray  was  seen even when  the  mutant  polypeptide (NFM- 
CA443)  was  only  0.02%  of total  cellular  protein  (line 
CA443E), while the vimentin content was 2%.  Therefore, 
as little as 1 part in 100 of this mutant polypeptide (deleted 
only five amino acids into the rod domain) is sufficient to dis- 
rupt assembly of  a portion of  the vimentin network of  L cells. 
Further, examination of the growth rate of the mutant cells 
revealed no differences relative to the parental cells with in- 
tact arrays, demonstrating that the partial disruption of the 
IF array did not affect mitotic growth. 
Construction and Expression of  Amino-terminal 
Deletions of  NF-M 
We also generated a set of amino-terminal deletions begin- 
ning with the construct pNFM-CA50 already tagged with 
c-myc at its carboxy terminus. From this, we used exonucle- 
ase [] to generate a series of amino-terminal deletions into 
the NF-M coding region. To provide an appropriate transla- 
tion initiation site, the 5' untranslated region together with 
the first two codons of NF-L were added (see Fig.  7  and 
Materials and Methods). DNA sequencing was used to iden- 
tify deletions in which the ATG was linked to the correct 
reading frame of NF-M.  The mutant constructs (Fig.  8 A) 
are denoted by pNFM-NAy, where y refers to the number of 
amino acids removed from the amino-terminal domain of 
NF-M (the precise end point of each deletion is marked in 
Fig.  1). 
Each construct was transfected into mouse fibroblasts and 
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Protein samples were resolved by SDS-PAGE and immuno- 
blotted with the monoclonal antibody against the myc tag, AS 
shown in Fig. 8 B (lanes b-g), a single immunoreactive poly- 
peptide was detected in each transfected cell extract. In all 
cases, the size was consistent with that predicted from the 
sequence data. By using parallel immunoblotting of known 
molar amounts of myc-bearing fusion proteins combined 
with immunofluorescence that revealed ,~20% of the cells 
were  successfully transfected, we calculate that in trans- 
fected cells the molar ratio of  mutant polypeptide to endoge- 
nous vimentin ranged from '~1:2 (for mutant pNFM-NA42) 
to '~1:50 (for mutant pNFM-NAI39). 
NF-M Truncated in Up to 70% of 103 Amino Acid 
Head Domain Retains Coassembly Competence 
To test whether the removal of portions of the nonhelicai 
amino-head domain yields an assembly-competent NF-M 
subunit, L-cells were transiently transfected with constructs 
pNFM-NA42 and pNFM-NA75 and examined by indirect 
irmnunofluorescence.  As  before,  a  monoclonal  antibody 
against the myc tag was used to visualize the presence of 
NF-M  mutant polypeptides,  while a  polyclonal antibody 
against vimentin was used to detect the vimentin array. As 
shown in Fig. 9, A and B, the NF-M polypeptide truncated 
in the amino-terminal 42 residues (NFM-NA42) was incor- 
porated into a fine filamentous array that completely colocal- 
ized with the endogenous vimentin network. Further trunca- 
tion of the first 75 amino acids yielded a subunit that also 
continued to colocalize with vimentin (Fig. 9,  C and D). 
However, while the vimentin array was like that in untrans- 
fected cells,  in most transfected cells the NF-M  subunits 
were more prominently localized to the perinuclear region 
with only weak staining appearing at the most peripheral 
portions  of the  cytoplasm.  Therefore,  while perhaps  not 
completely wild type, it is clear tllat NF-M molecules miss- 
ing up to 70 % of the nonhelical amino-head domain retain 
substantial competency for assembly into IF networks, at 
least in the presence of wild-type vimentin polypeptides. 
Semirecessive Amino-Terminal Mutants Identify 
a Determinant Necessary for Efficient Assembly into 
IF Arrays 
We also transfected mutant constructs deleted into the rod 
from the amino terminus (e.g., pNFM-NA126 to pNFM- 
NA266;  Fig.  8).  A  mutant polypeptide deleted 23  amino 
acids into the rod domain (pNFM-NA126) was assembly in- 
competent as reflected by the diffuse cytoplasmic staining 
pattern (Fig. 9 E), a pattern seen in all transfected cells. In 
contrast with the dominant carboxy-terminal rod mutants, 
the presence of this mutant polypeptide did not lead to com- 
plete collapse of the endogenous vimentin array in any of the 
transfected cells (Fig. 9 F) even though quantitative immu- 
noblotting revealed that its average abundance relative to 
vimentin (1:50) was similar to disruptive carboxy-terminal 
mutants. Instead, the vimentin remained filamentous but the 
arrays appeared comprised of many fine filaments. Deletion 
of an additional 13 amino acids to remove the entirety of he- 
lix  la (pNFM-NA139)  yielded a  subunit that localized to 
perinuclear aggregates (Fig. 9 G). Although its average level 
was again 1/50th the level of vimentin, the vimentin network 
was only partially fragmented, appearing as a  fine mesh- 
work of apparently shorter,  cytoplasmic filaments (Fig. 9 
H).  Clearly,  these  amino-terminal  rod  mutations  yield 
subunits that for the most part fail to interact (i.e., localize) 
with wild-type IF subunits.  Vimentin remains assembled 
into filaments, but the mutants fragment the normal IF array 
into a finer filamentous network. Further deletions into the 
rod (pNFM-NA236 and pNFM-NA266) yielded no detect- 
able immunofluorescence signals in cytoskeleton prepara- 
tions. Since the mutant polypeptides were detected by immu- 
noblotting (Fig.  8,  lanes f  and g), we conclude that these 
polypeptides are incompetent for assembly into filaments 
and are soluble. Since none of the amino-terminal rod dele- 
tions we examined colocalized with or disrupted assembly 
of vimentin into  filaments,  we  conclude  that  sequences 
within the region spanning residues 75-126  of NF-M are 
necessary for its efficient interaction with vimentin to form 
dimers and/or other oligomers. 
Mutations of NF-M Near the Carboxy-Terminal Rod 
Domain Disrupt NF-L Arrays 
Since it was possible that the domains of NF-M required for 
coassembly with vimentin differ from those necessary for as- 
sembly with its normal partner NF-L, we also examined the 
consequences of expression of mutant NF-M subunits in a 
cell line (MSV-NF9;  Monteiro and Cleveland [1989])  that 
stably accumulates NF-L to high levels ('~8% of cell pro- 
tein).  Various  carboxy-terminal deletion  constructs  were 
transiently transfected into MSV-NF9 cells and protein ex- 
tracts immunoblotted. Polypeptides of the expected molecu- 
lar masses (shown in Fig. 3 B, lanes k-q) were observed. As 
before, indirect immunofluorescence with a monoclonai an- 
tibody against the myc tag was used to stain for the presence 
of NF-M polypeptides while a polyclonal antibody against 
NF-L was used to stain the endogenous NF-L array.  As 
shown in Fig. 10 A and B, the polypeptide encoded by pNFM- 
CA197  (as  well as pNFM-CA50 and pNFM-CA391;  not 
shown) was coassembled into the NF-L array. Thus, NF-M 
mutant polypeptides missing up to 90% of their carboxy-tail 
domain assembled properly into the NF-L array. In contrast, 
mutants deleted closer to the carboxy-terminal rod domain 
were dominant disruptors of NF-L arrays in 50%  of the 
transfected cells. For example, as shown by the eelI in the 
center of Fig.  10,  C and D, transfection of pNFM-CA438 
(deleted in the entire taft) yielded punctate staining contain- 
ing NF-M and wild-type NF-L throughout the cytoplasm, as 
well as large perinuclear aggregates. This disruption of NF-L 
Figure 9. Assembly properties of NF-M subunits missing portions or the entirety of the nonhelical amino-head domain. Mouse L cells 
grown on coverslips were transfected with (A and B) plasmids pNFM-NA42, (C and D) pNFM-NA75, (E and F) pNFM-NA126, and 
(G and H) pNFM-NA139. Cells were stained 40 h after transfection as described in Fig. 4 for (A, (7, E, and G) NF-M subunits and (B, 
D, F, and H) endogenous vimentin. Bar, 10 #m. 
Wong and Cleveland  Assembly-disrupting  Mutations  of NF-M  1997 Figure 1L NF-M molecules missing 70% of the amino-head and 90% of the earboxy-tail domains are assembly-disrupting dominant mu- 
tants. Mouse L ceils grown on coverslips were transfected with plasmid pNFM-NA75/CA931. (A) The mutant NF-M polypeptides were 
detected 40 h postlransfection using Mycl-9E10 monoclonai antibody followed by fluorescein-conjugated rabbit anti-mouse IgG and (B) 
vimentin was visualized in the same transfected cells with a goat polyclonal vimentin antibody followed by a rhodamine-conjugated rabbit 
anti-goat IgG. Bar, 10 ttm. 
arrays was  seen as early as  19-h posttransfection and oc- 
curred at average NF-M/NF-L stoichiometries of 1:20. Some 
NFM-CA438 expressing cells showed more normal IF ar- 
rays (e.g., the cell at the lower right in Fig.  10, C and D). 
NF-M Subunits Truncated into the Amino-terminal 
Rod Domain Do Not Disrupt NF-L Arrays 
When amino-terminal NF-M deletion constructs were trans- 
fected into NF-L expressing MSV-NF9 cells, each construct 
directed the synthesis of the predicted NF-M mutant poly- 
peptide (revealed by immunoblot; Fig. 8 B, lanes h-m).  In- 
direct immunofluorescence examination of the transfected 
cells again showed that mutant polypeptides missing up to 
70 % of their amino-head domain remained assembly com- 
petent.  Mutant  polypeptides  missing  42  amino-terminal 
residues  (NFM-NA42;  Fig.  10,  E  and F)  or 75  residues 
(NFM-NA75; not shown) incorporated properly into the en- 
dogenous  NF-L  array.  However, mutations  that  extended 
into the rod domain were not assembly competent and the 
mutant polypeptides formed a large aggregate adjacent to the 
nucleus (such as NFM-NA139; Fig. 10 G). The correspond- 
ing endogenous NF-L array still retained a network of NF-L- 
containing filaments (Fig.  10 H), although as in the case of 
vimentin-expressing cells (Fig. 9 H) the IF array appeared 
fragmented into a meshwork of finer filaments. While this 
suggests that such mutants result in a  minor disruption in 
NF-L arrays  (at a  NF-M/NF-L  ratio  of 1:25  as  revealed 
by quantitative immunoblotting), it is clear that efficient as- 
sociation of NF-M into NF-L dimers, oligomers, and/or ilia- 
ments requires some residues in the amino-terminal domain 
between 75 and  126. 
Identi~ng the Minimal NF-M Domain That Is 
Assembly Competent 
Having determined that subunits truncated to leave at least 
28 amino acids of the head (NFM-N~75) or 47 amino acids 
of the tail (NFM-CA391) retained full coassembly compe- 
tence, we next tested whether NF-M truncated to these anaino- 
and carboxy-terminal borders defined the minimal assembly 
competent domain. A gene missing 75 residues of  the amino- 
and  391  residues of the carboxy-terminal domain (NFM- 
NA75/CA391)  was  prepared.  Transfection of this  nearly 
headless and tailless NF-M gene revealed two phenotypes. 
In 30% of the transfected cells the mutant NF-M subunits 
were assembly competent and coaligned with the vimentin 
array (e.g., the cell at the right in Fig.  11, A and B). How- 
ever,  in  the  majority of the transfected cells,  the mutant 
NF-M produced a dominant phenotype that was reminiscent 
of the  carboxy-terminal assembly-disrupting  mutants.  As 
shown by the cell at the left in Fig.  11, A and B, the mutant 
polypeptide was colocalized with vimentin into a disrupted 
an'ay that contained punctate cytoplasmic aggregates and a 
collapsed perinuclear mass.  Similar results were obtained 
when the same gene was transfected into NF-L expressing 
MSV-NF9 cells (not shown). Even after restoring an addi- 
tional 33 amino-terminal residues (NFM-NA42/CA391) we 
observed disruption in '~70% of transfected cells. Since nei- 
ther deletion of the amino-terminal 75 residues or as many 
Figure 10. Expression of mutant NF-M polypeptides in fibroblasts that stably express high levels of NF-L. MSV-NF9 cells grown on cover- 
slips were transiently transfected with (.4 and B) pNFM-CAI97, (C and D) pNFM-CA438, (E and F) pNFM-NA42, or (G and H) pNFM- 
NA139. Ceils were stained 40 h after transfection with the Mycl-9E10 monoclonal antibody followed by fluoreseein-eonjugated rabbit 
anti-mouse  IgG to visualize the NF-M mutant polypeptides and a rabbit polyclonal NF-L antibody followed by rhodamine-eonjugated 
goat anti-rabbit IgG to detect the endogenous NF-L array. (A, C, E, and G) NF-M staining; (B, D, F,, and H) NF-L staining. Bar, 10 gm. 
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C and 9 C), these findings demonstrate that the nonhelical 
domains do play some role in assembly of NF-M into IF 
arrays. 
Disruption of Vimentin Arrays Occurs with a 
Half-Time of  Less Than 3 h 
To examine the rapidity with which an endogenous wild-type 
IF  array  could  be  disrupted  by  expression  of a  mutant 
subunit, we followed the accumulation of an assembly dis- 
rupting dominant mutant (deleted five amino acids into the 
carboxy-terminal rod domain) after transient transfection. 
The earliest time at which mutant protein was detectable by 
immmunofluorescence was 15-h posttransfection (Fig. 12, A 
and C). These newly accumulated mutants localized to a se- 
ries of dispersed cytoplasmic aggregates (which contained 
too little protein to be quantified by immunoblot) that also 
contained wild-type vimentin (Fig. 12 D). These aggregates 
had little effect on the overall vimentin array which remained 
nearly fully assembled (Fig.  12 D).  However, in a  subse- 
quent 4-h period, a level of mutant polypeptide accumulated 
to yield an average content in transfected cells of 1:200 for 
NF-M/vimentin and immunofluorescence demonstrated that 
this was accompanied by partial disruption of the endoge- 
nous IF array (Fig.  12, B and F). In most cells expressing 
this mutant,  complete disruption of the endogenous array 
(Fig. 12, G and H) was seen 24-h posttransfection (9 h after 
the mutant protein was  first observed),  when the average 
proportion of mutant to vimentin had risen to 1:50. The es- 
sentially complete disruption of the endogenous filament ar- 
ray within a 9-h period indicates that in the presence of mu- 
tant  subunits,  collapse  or  disassembly  of the  array  must 
occur with a half time of 3 h or less. 
Discussion 
The use of DNA transfection to force coexpression of trun- 
cated NF-M subunits with either wild-type vimentin or NF-L 
polypeptides has allowed us an initial examination of the do- 
mains essential for in vivo assembly of this neurofilament 
subunit. As might have been anticipated, no mutation from 
either the amino or carboxy terminus that truncates into the 
predicted  helical  domain  yields  an  assembly  competent 
subunit; rather, in addition to the 310 amino acid rod, the 
minimal NF-M domain that we have shown to coassemble 
includes 26 amino acids of the head. While at the carboxy 
terminus deletions that precisely remove the entire tail (e.g., 
NFM-CA438) can be assembled, this conclusion is mislead- 
ing since this NF-M mutant (as well as one with nine addi- 
tional amino acids of  the tail) become array-disrupting domi- 
nant mutants when expressed at higher ratios to wild-type 
subunits (Fig. 10, Cand D). While in vitro assembly experi- 
ments with these or similar mutant polypeptides will be re- 
quired to establish definitively the precise assembly products 
of  wild-type  and  mutant  polypeptides  (and  at  various 
stoichiometries), our stable transfectants that express NF-M 
subunits truncated into the NF-M rod yield an unambiguous 
in  vivo finding:  mutations  in  this  domain  are  invariably 
assembly-disrupting mutants even when accumulated to lev- 
els only 1% of the wild-type subunit. 
The minimal NF-M subunit that retains assembly compe- 
tence (but only when present in low molar amounts) con- 
tained 30 amino acids of head and 47 amino acids of tail do- 
main,  respectively,  in  addition  to  the  complete  helical 
segment. That the rod domain is largely sufficient for assem- 
bly is consistent with preceding analyses of other intermedi- 
ate filament subunits. By using a transfection protocol after 
which we modeled our experiments, Albers and Fuchs (1987, 
1989) documented that a minimal domain of  the type I human 
keratin K14 required for coassembly with a wild-type type 
II keratin was limited to the rod domain preceded by an eight 
amino acid head. Dispensability of at least one of the two 
tails in the keratin heterodimer of one type I and one type 
II chain was also emphasized in a more natural context by 
discovery of a bovine keratin (K19) that is nearly tailless 
(Bader et al.,  1986).  However, the conclusion that the rod 
domain alone is sufficient for assembly of an IF network may 
be misleading, since it is not known whether a taiUess pair 
of type I and II keratins can assemble. We have shown here 
that the rod elements of NF-M (and in the companion paper 
of NF-L; Gill et al.,  1990) cannot support filament network 
assembly without assistance from wild-type subunits.  Wheth- 
er rod elements alone can support assembly of the type HI 
IF subunits is not yet tested. Neither is the case clear at pres- 
ent for nuclear lamins since truncation of the lamin A tail 
results in aberrant cytoplasmic assembly due (at least in part) 
to deletion of the nuclear localization signal carried within 
the tail domain (Loewinger and McKeon,  1988). 
Further distinctions from the previous work with keratins 
are the effects of amino-terminal truncations. Deletions into 
the helical domain from either the carboxy or amino termi- 
nus of type I human keratin K14 yield mutant subunits that 
disrupt networks of wild-type type I and II keratins (Albers 
and Fuchs, 1987, 1989). Moreover, the amino-terminal mu- 
tations are sufficiently severe that cells expressing them do 
not recover from transient expression (Albers and Fuchs, 
1989). In contrast, for NF-M (and NF-L; Gill et al.,  1990) 
the amino-terminal deletions, while assembly incompetent, 
are at least partially recessive and affect the wild-type fila- 
ment array much less markedly than do the carboxy-terminal 
mutants. We infer that this ~pseudo"  recessive nature reflects 
the deletion of a domain(s) (within amino acids 76-126 of 
NF-M) that is necessary for efficient interaction with normal 
subunits. Of course, we do not put too fine a point on it since 
in vitro reassembly reactions are required to document this 
more directly. 
Indeed, despite the strength of such transfection experi- 
ments in their ability to track the overall IF network, this ap- 
proach also brings an inherent weakness: the limited resolu- 
Figure 12. Kinetics of endogenous IF disruption during accumulation of an assembly-disrupting NF-M mutant (NFM-CA443). L cells 
grown on coverslips were transiently transfected with pNFM-CA443. Cells were stained (.4, C, and D) 15, (B, E, and F) 19, or (G and 
H) 24-h post-transfection. NFM-CA443 polypeptides or vimentin were visualized as described in earlier figures. (,4, C, E, and G) NFM- 
CA443 staining; (B, D, F, and H) vimentin staining. Cand D, Eand F, and G and Hare pairs of  double immunofluorescent images visualiz- 
ing NFM-CA443 and vimentin. A and B are images of cells stained only for (,4) NFM-CA443, or (B) vimentin. Bar, 10 izm. 
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(at formation of dimers, tetramers, or other oligomers). In- 
deed, it is possible that some of the mutant polypeptides are 
assembled into bona fide filaments, but that incorporation of 
the mutants disrupts competence for other interactions need- 
ed for assembly or maintenance of extended IF arrays. Elec- 
tron microscopic analysis as well as the in vitro assembly ex- 
periments  mentioned above  are  needed to  address  more 
clearly the underlying structure(s) of the aggregates formed. 
Another caution that tempers interpretation of mutagene- 
sis experiments is that the failure of a mutant (either point 
or deletion) to share a property of  the wild-type  protein (e.g., 
assembly competence) may not be due to mutation within a 
domain required for that property. Rather, it may result from 
mutagenesis-induced changes in protein conformation in a 
remaining (most often adjacent) domain. In this regard, the 
formal possibility remains that some of the assembly disrup- 
tive properties of the mutant subunits may derive from the 
carboxy-terminal myc tag, although given the apparent wild- 
type assembly of other mutants carrying the same tag, we 
consider this unlikely. 
A final ambiguity that arises from transient expression is 
the precise level of accumulation. While we have accurately 
measured the average level of accumulation, we cannot be 
certain of the level in individual cells. Based on fluorescence 
intensity, we believe that for those mutants displaying coas- 
sembly in some ceils, but disrupting arrays in others (e.g., 
NFM-CA438),  the  differences in  phenotype result  from 
differences in the amount of mutant. However, another (not 
mutually exclusive) explanation is cell cycle-dependent dis- 
ruption of IF arrays, a clearly interesting possibility, but one 
not yet addressed by our experiments. 
In any event, the relatively rapid disruption of endogenous 
vimentin (or NF-L) reinforces that IF arrays must be dy- 
namic. This point was unequivocally established for keratins 
when Albers and Fuchs (1989) showed that mutant keratins 
initially caused a  retraction of the keratin array from the 
plasma membrane, followed by collapse and disruption of 
the entire network. For the type [] (vimentin) and type IV 
(NF)  arrays analyzed here, we find substantial disruption 
within a 4-h period during which the mutant NF-M is first 
accumulated. Even at the time that disruption is complete 
(,o9 h after first appearance of the mutant), we calculate the 
average level in transfected cells of  mutant subunit to be only 
"ol/50 of the wild type. The disassembly and localization of 
wild-type subunits into coaggregates with newly made mu- 
tant polypeptides isconsistent with only two general scenar- 
ios (which are not mutually exclusive): either IF filaments 
have an intrinsic dynamic behavior with a maximal filament 
half-fife of < 3 h (such a half life would yield disassembly 
of ,o90 % of the initial IF array in 9 h) or subunits freely ex- 
change along the length of existing filaments. In the first pos- 
sibility, mutant subunits would block re.assembly  of wild- 
type proteins liberated by natural or mutant-induced filament 
disassembly.  In the  second,  incorporation of the mutant 
subunits along the length could trigger filament fragmenta- 
tion leading ultimately to disruption of the entire wild-type 
array. This latter possibility is particularly appealing in view 
of  STEM measurements that have indicated that in vitro reas- 
sembled keratin IFs (Steven et al., 1983; Engel et al., 1985) 
or native NF (Aebi et al., 1988) do not have a constant num- 
ber of  IF subunits per unit length. This is also consistent with 
the finding that newly synthesized vimentin subunits are ap- 
parently incorporated at many sites along the length of exist- 
ing filaments (Ngai et al.,  1990). 
The in vivo role of intermediate filaments has been a most 
troublesome question. Neither the absence nor (as we have 
now shown) disruption of type HI IF arrays affects mitotic 
growth of cultured cells. Indeed, there is no compelling ex- 
perimental evidence that establishes an in vivo function of 
any IF protein. However, for NF, we and our colleagues have 
identified a strong correlation in mammals between NF con- 
tent and axonal diameter in large bore, myelinated axons of 
the peripheral nervous system (Hoffman et al., 1984,  1985, 
1987; Hoffman and Cleveland, 1988).  The identification of 
assembly-disrupting dominant mutants,  as  we have done 
here, should now allow a direct test of this potential function 
by analysis of the consequences in transgenic mice of in vivo 
expression of these mutant NF-M subunits. 
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Note Added in Proof. X. Lu and E. B. Lane (1990. Cell. 62:681-696) have 
recently reported coexpression of both wild-type and mutant type I and II 
keratin genes in fibroblast cells that accumulate no endogenous keratin fila- 
ments. Similar to our finding that a portion of the head and tail domains 
are required for assembly of  NF-M, they found that keratin filament assem- 
bly requires intact amino- and carboxy-terminal domains on at least one of 
the two subunits. 
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